GAL3ST1 and renal cell adenocarcinoma: Despite two major statistical limitations of our cohort—relatively small sample size and heterogeneity, (1) classical risk factors showed here significant impact on the outcome and thereby confirmed the representative character of the cohort, (2) multivariate confounder-adjusted analysis showed similar results and (3) supporting our data, the analysis of mRNA expression of Gal3ST1 from an independent, larger representative TCGA dataset of RCC revealed no significant impact of Gal3ST1 on overall survival.